Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00288002
Status:
COMPLETED
Last Update Posted:
2013-08-26
First Post:
2006-02-06
Brief Title:
Combination Chemotherapy With or Without Capecitabine andor Trastuzumab Before Surgery in Treating Women With Stage I Stage II or Stage III Breast Cancer
Sponsor:
German Breast Group
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000455125
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German Breast Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None